Brazil Biotechnology Âé¶¹Ô´´ Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Biotechnology in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The Brazilian biotechnology market had total revenues of $15.2 billion in 2021, representing a compound annual growth rate (CAGR) of 6.6% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $8.2 billion, equivalent to 54% of the market's overall value.
- The Brazilian market has benefited from a range of different drivers, including subsidized credit for GMO farmers and sponsorship by the Structural Genomics Consortium for a biotech cluster around the University of Campinas in São Paulo.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Brazil
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Brazil biotechnology market by value in 2021?
- What will be the size of the Brazil biotechnology market in 2026?
- What factors are affecting the strength of competition in the Brazil biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Brazil's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Âé¶¹Ô´´ value
1.2. Âé¶¹Ô´´ value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Âé¶¹Ô´´ rivalry
1.6. Competitive Landscape
2 Âé¶¹Ô´´ Overview
2.1. Âé¶¹Ô´´ definition
2.2. Âé¶¹Ô´´ analysis
3 Âé¶¹Ô´´ Data
3.1. Âé¶¹Ô´´ value
4 Âé¶¹Ô´´ Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Âé¶¹Ô´´ Outlook
5.1. Âé¶¹Ô´´ value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What opportunities are there for leading players?
8 Company Profiles
8.1. Sanofi SA
8.2. EMS SA
8.3. Braskem SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related Âé¶¹Ô´´Line research
10.4. About Âé¶¹Ô´´Line
List of Tables
List of Tables
Table 1: Brazil biotechnology industry value: $ billion, 2016–21
Table 2: Brazil biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Brazil biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Brazil biotechnology industry geography segmentation: $ billion, 2021
Table 5: Brazil biotechnology industry value forecast: $ billion, 2021–26
Table 6: Sanofi SA: key facts
Table 7: Sanofi SA: Annual Financial Ratios
Table 8: Sanofi SA: Key Employees
Table 9: Sanofi SA: Key Employees Continued
Table 10: EMS SA: key facts
Table 11: EMS SA: Key Employees
Table 12: Braskem SA: key facts
Table 13: Braskem SA: Annual Financial Ratios
Table 14: Braskem SA: Key Employees
Table 15: Brazil size of population (million), 2017–21
Table 16: Brazil gdp (constant 2005 prices, $ billion), 2017–21
Table 17: Brazil gdp (current prices, $ billion), 2017–21
Table 18: Brazil inflation, 2017–21
Table 19: Brazil consumer price index (absolute), 2017–21
Table 20: Brazil exchange rate, 2017–21
List of Figures
List of Figures
Figure 1: Brazil biotechnology industry value: $ billion, 2016–21
Figure 2: Brazil biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Brazil biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Brazil biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Brazil, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Brazil, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Brazil, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Brazil, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Brazil, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Brazil, 2021
Sanofi SA
EMS SA
Braskem SA
Ìý
Ìý
*If Applicable.